Basic Information
Basic information for MIR9-3HG-227-36aa-1
Peptide Name MIR9-3HG-227-36aa-1
Genome Position chr15:89397597-89397704[+]
Species Human
Peptide Sequence MGLSRGAWETWSLRPGHSYNHFKLAVGPVDWEGKKQ
Peptide Length 36
Unique No (MIR9-3HG-201-36aa-2,MIR9-3HG-212-36aa-2,MIR9-3HG-213-36aa-2,MIR9-3HG-214-36aa-1,MIR9-3HG-218-36aa-1,MIR9-3HG-219-36aa-1,MIR9-3HG-220-36aa-2,MIR9-3HG-221-36aa-2,MIR9-3HG-222-36aa-1,MIR9-3HG-226-36aa-2,MIR9-3HG-233-36aa-1,MIR9-3HG-241-36aa-1,MIR9-3HG-246-36aa-1,MIR9-3HG-247-36aa-2,MIR9-3HG-251-36aa-1,MIR9-3HG-252-36aa-1,MIR9-3HG-253-36aa-1)
Grand Average of Hydropathicity -0.8
Relative Molecular Mass 4757.2
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000661040;MIR9-3HG-227
Transcript Length 4092
Coding Ability 0.4824
DNA Sequence Corresponding to Peptide ATGGGGCTGTCCAGAGGGGCCTGGGAAACCTGGTCCCTGAGGCCTGGGCACAGCTACAATCACTTCAAATTGGCTGTGGGGCCAGTGGACTGGGAAGGAAAAAAGCAA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :